Exact Mass: 577.1528

Exact Mass Matches: 577.1528

Found 32 metabolites which its exact mass value is equals to given mass value 577.1528, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Clazosentan

N-[6-(2-Hydroxyethoxy)-5-(2-methoxyphenoxy)-2-[2-(2H-1,2,3,4-tetrazol-5-yl)pyridin-4-yl]pyrimidin-4-yl]-5-methylpyridine-2-sulphonamide

C25H23N9O6S (577.1492)

C28313 - Endothelin Receptor Antagonist Clazosentan (Ro 61-1790) is a selective endothelin A (ETA) receptor antagonist. Clazosentan inhibits ET-1-mediated vasoconstriction. Clazosentan prevents cerebral vasospasm, vasospasm-related cerebral infarction[1][5].

Asp Glu Glu Trp

(4S)-4-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-carboxybutanamido]-4-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C25H31N5O11 (577.202)

Asp Glu Trp Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-carboxybutanamido]-3-(1H-indol-3-yl)propanamido]pentanedioic acid

C25H31N5O11 (577.202)

Asp Trp Glu Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-(1H-indol-3-yl)propanamido]-4-carboxybutanamido]pentanedioic acid

C25H31N5O11 (577.202)

Glu Asp Glu Trp

(4S)-4-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-carboxypropanamido]-4-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C25H31N5O11 (577.202)

Glu Asp Trp Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-carboxypropanamido]-3-(1H-indol-3-yl)propanamido]pentanedioic acid

C25H31N5O11 (577.202)

Glu Glu Asp Trp

(4S)-4-[(2S)-2-amino-4-carboxybutanamido]-4-{[(1S)-2-carboxy-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C25H31N5O11 (577.202)

Glu Glu Trp Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-4-carboxybutanamido]-3-(1H-indol-3-yl)propanamido]butanedioic acid

C25H31N5O11 (577.202)

Glu Trp Asp Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-(1H-indol-3-yl)propanamido]-3-carboxypropanamido]pentanedioic acid

C25H31N5O11 (577.202)

Glu Trp Glu Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-(1H-indol-3-yl)propanamido]-4-carboxybutanamido]butanedioic acid

C25H31N5O11 (577.202)

Trp Asp Glu Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-carboxypropanamido]-4-carboxybutanamido]pentanedioic acid

C25H31N5O11 (577.202)

Trp Glu Asp Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-carboxybutanamido]-3-carboxypropanamido]pentanedioic acid

C25H31N5O11 (577.202)

Trp Glu Glu Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-carboxybutanamido]-4-carboxybutanamido]butanedioic acid

C25H31N5O11 (577.202)

sodium 4-[4-[[3-[(ethylanilino)sulphonyl]-4-methylphenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonate

C25H24N5NaO6S2 (577.1066)

stilbazium iodide

C31H36IN3 (577.1954)

Fmoc-Asp(OtBu)-Opfp

C29H24F5NO6 (577.1524)

NAPHTHOL AS-MX-PHOSPHATE DISODIUM SALT NONAHYDRATE

C19H34NNa2O14P (577.1512)

NEU5AC ALPHA(2-3)GAL BETA MP GLYCOSIDE

C24H35NO15 (577.2007)

Clazosentan

N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-[2-(2H-tetrazol-5-yl)pyridin-4-yl]pyrimidin-4-yl]-5-methyl-pyridine-2-sulfonamide

C25H23N9O6S (577.1492)

Vitexin 2-O-beta-L-rhamnoside

C27H29O14- (577.1557)

pelargonidin 3-O-beta-D-p-coumaroylglucoside

C30H25O12- (577.1346)

cicerin-7-O-glucoside-6-malonate

C26H25O15- (577.1193)

6-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]-7-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-5-olate

C27H29O14- (577.1557)

2-[[3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl]-oxomethyl]imino-1-(2-methylpropyl)-5-oxo-3-dipyrido[1,2-d:3,4-f]pyrimidinecarboxylic acid ethyl ester

C29H25ClFN5O5 (577.1528)

(3S,3S,4R,5S)-5-(2-hydroxyethyl)-5-iodo-4-[(4-methoxyphenyl)-dimethylsilyl]-3-methyl-1-prop-2-enyl-2-spiro[indole-3,2-oxolane]one

C26H32INO4Si (577.1145)

vitexin 2-O-alpha-L-rhamnoside(1-)

C27H29O14- (577.1557)

The conjugate base of vitexin 2-O-alpha-L-rhamnoside arising from deprotonation of the OH group at position 7 on the chromene.

vitexin 2-O-beta-L-rhamnoside(1-)

C27H29O14 (577.1557)

A flavonoid oxoanion that is the conjugate base of vitexin 2-O-beta-L-rhamnoside obtained by deprotonation of the OH group at position 7 on the chromene. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

n-[(2r,3r,4r,5r,6s)-3-(acetyloxy)-6-{5-ethenyl-15-hydroxy-3,17-dimethoxy-8-oxo-9-oxatetracyclo[8.8.0.0²,⁷.0¹¹,¹⁶]octadeca-1(10),2(7),3,5,11(16),12,14,17-octaen-12-yl}-5-hydroxy-2-methyloxan-4-yl]ethanimidic acid

n-[(2r,3r,4r,5r,6s)-3-(acetyloxy)-6-{5-ethenyl-15-hydroxy-3,17-dimethoxy-8-oxo-9-oxatetracyclo[8.8.0.0²,⁷.0¹¹,¹⁶]octadeca-1(10),2(7),3,5,11(16),12,14,17-octaen-12-yl}-5-hydroxy-2-methyloxan-4-yl]ethanimidic acid

C31H31NO10 (577.1948)

n-[3-(acetyloxy)-6-{5-ethenyl-15-hydroxy-3,17-dimethoxy-8-oxo-9-oxatetracyclo[8.8.0.0²,⁷.0¹¹,¹⁶]octadeca-1(10),2(7),3,5,11(16),12,14,17-octaen-12-yl}-5-hydroxy-2-methyloxan-4-yl]ethanimidic acid

n-[3-(acetyloxy)-6-{5-ethenyl-15-hydroxy-3,17-dimethoxy-8-oxo-9-oxatetracyclo[8.8.0.0²,⁷.0¹¹,¹⁶]octadeca-1(10),2(7),3,5,11(16),12,14,17-octaen-12-yl}-5-hydroxy-2-methyloxan-4-yl]ethanimidic acid

C31H31NO10 (577.1948)